Prostate Cancer

Top Story

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016

Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational study.

Further, the incidence of delirium was comparable among younger and older patients, suggesting all patients with advanced cancer are at risk.

Editorial

Word salad: What’s for dessert?

HemOnc Today, July 25, 2016
Derek Raghavan, MD, PhD
I enjoyed this year’s ASCO Annual Meeting. The program committee has finally taken very seriously the entreaties from Lowell E. Schnipper, MD, and the gang…

ACS executive says prostate cancer study used ‘flawed analysis,’ researcher disputes ‘false accusations’

July 21, 2016
An observational study that showed a dramatic increase in metastatic prostate cancer cases over the past decade relied on “a flawed analysis” and cannot…

What cancer screenings are recommended for men?

July 21, 2016
Men have a 42% chance of developing invasive cancer during their lifetime, and a nearly 23% chance of dying of cancer, according to American Cancer Society statistics…
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Video
Meeting News Coverage

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016
Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a…

Editorial

Word salad: What’s for dessert?

HemOnc Today, July 25, 2016
Derek Raghavan, MD, PhD
I enjoyed this year’s ASCO Annual Meeting. The program committee has finally taken very seriously the entreaties from Lowell E. Schnipper

ACS executive says prostate cancer study used ‘flawed analysis,’ researcher disputes ‘false accusations’

July 21, 2016
An observational study that showed a dramatic increase in metastatic prostate cancer cases over the past decade relied on “a flawed…

What cancer screenings are recommended for men?

July 21, 2016
Men have a 42% chance of developing invasive cancer during their lifetime, and a nearly 23% chance of dying of cancer, according to American Cancer…

In the Journals

Incidence of metastatic prostate cancer increases 72% in a decade

July 19, 2016
The number of new cases of metastatic prostate cancer increased by 72% between 2004 and 2013, according to an analysis of the National Cancer Data…

Memorial Sloan Kettering program designed to meet needs of teens, young adults with cancer

July 13, 2016
Memorial Sloan Kettering Cancer Center launched a new initiative designed to help teens and young adults with cancer. The program offers services to…

In the Journals

Cancer center advertising expenditures more than triple since 2005

July 11, 2016
Cancer treatment centers in the United States spent $173 million on advertising in the year 2014, according to a research letter published in JAMA

In the Journals

Cancer risk increased before, after diabetes diagnosis

July 11, 2016
Individuals with type 2 diabetes appeared to have an increased risk for cancer 3 months following and 10 years preceding their diabetes diagnosis…

American Society for Radiation Oncology names honorary member

July 10, 2016
Haakon Ragde, MD, has been selected as the American Society for Radiation Oncology’s honorary member for 2016. Honorary membership is the…

In the Journals

Researchers: Genetic testing should be standard for metastatic prostate cancer

July 6, 2016
Men with metastatic prostate cancer appeared significantly more likely to harbor germline mutations in DNA repair genes than those with localized…

More Headlines »
morganatic-roan